These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3321596)

  • 1. The effect of anti-L3T4 monoclonal antibody treatment on first-set rejection of murine cardiac allografts.
    Madsen JC; Peugh WN; Wood KJ; Morris PJ
    Transplantation; 1987 Dec; 44(6):849-52. PubMed ID: 3321596
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of L3T4 and Lyt-2 monoclonal antibodies on islet xenograft (rat to mouse) rejection.
    Kawai M; Gotoh M; Monden M; Yamamoto H; Ichikawa T; Valdivia LA; Mori T; Uenaka A; Nakayama E
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2709-10. PubMed ID: 2495677
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of the L3T4+ T cell in allograft rejection.
    Hao L; Wang Y; Gill RG; Lafferty KJ
    J Immunol; 1987 Dec; 139(12):4022-6. PubMed ID: 3121726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between CD4 and CD8 T cells determines graft outcome in monoclonal antibody-treated mice.
    Hamano K; Morris PJ; Wood KJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):792-3. PubMed ID: 8438483
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of anti-L3T4 and anti-Lyt 2 monoclonal antibodies on murine cardiac allograft rejection.
    Madsen JC; Wood KJ; Morris PJ
    Transplant Proc; 1987 Oct; 19(5):3991-2. PubMed ID: 3313979
    [No Abstract]   [Full Text] [Related]  

  • 6. Unconventional lymphocytes involved in rejection of xenogeneic heart grafts.
    Sakakibara N; Click RE; Sakakibara K; Aziz S; Jamieson SW; Wick MR
    Lab Invest; 1990 Apr; 62(4):481-6. PubMed ID: 2332971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful islet allografting requires depletion of both Lyt-2+ and L3T4+ cells.
    Yamamoto H; Monden M; Gotoh M; Ichikawa T; Kubota N; Kawai M; Mori T; Sakurai M; Uenaka A; Nakayama E
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2707-8. PubMed ID: 2495676
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule.
    Dialynas DP; Quan ZS; Wall KA; Pierres A; Quintáns J; Loken MR; Pierres M; Fitch FW
    J Immunol; 1983 Nov; 131(5):2445-51. PubMed ID: 6415170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine cardiac allograft survival following treatment of recipients with monoclonal anti-L3T4 or Ly-2 antibodies.
    Mottram PL; Wheelahan J; McKenzie IF; Clunie GJ
    Transplant Proc; 1987 Apr; 19(2):2898-901. PubMed ID: 3105127
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
    Guillonneau C; Aubry V; Renaudin K; Séveno C; Usal C; Tezuka K; Anegon I
    Transplantation; 2005 Aug; 80(4):546-54. PubMed ID: 16220623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of anti-L3T4 and anti-LYT2 monoclonal antibody therapy on cardiac allograft survival in presensitized recipients.
    Madsen JC; Wood KJ; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1022. PubMed ID: 2495588
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolongation of murine cardiac allografts following treatment of graft recipients with monoclonal anti-L3T4 and Ly-2 antibodies.
    Mottram PL; Wheelahan J; Mirisklavos A; Clunie GJ; McKenzie IF
    Transplant Proc; 1987 Feb; 19(1 Pt 1):582-5. PubMed ID: 3103281
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of rejection mechanism in the rat to mouse cardiac xenotransplantation. Role and characteristics of anti-endothelial cell antibodies.
    Matsumiya G; Shirakura R; Miyagawa S; Izutani H; Sawa Y; Nakata S; Matsuda H
    Transplantation; 1994 Jun; 57(11):1653-60. PubMed ID: 8009600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of anti-ICOS monoclonal antibody combined with low-dose CsA on chronic rejection of heart grafts in rats].
    Zhao YJ; Huang ZF; Cheng K; Zhu SH; Ye QF
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Nov; 33(11):1037-40. PubMed ID: 19060372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A potential immunosuppressive effect of anti-lymphocyte function-associated antigen-1 monoclonal antibody on islet transplantation.
    Gotoh M; Fukuzaki T; Monden M; Dono K; Kanai T; Yagita H; Okumura K; Mori T
    Transplantation; 1994 Jan; 57(1):123-6. PubMed ID: 7904780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synergistic effect of anti-CD4 monoclonal antibodies and cyclosporin A on murine fetal islet allograft survival.
    Burkhardt K; Charlton B; Mandel TE
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2663-4. PubMed ID: 2495663
    [No Abstract]   [Full Text] [Related]  

  • 18. CD4+ lymphocytes play a dominant role in murine xenograft rejection.
    Pierson RN; Winn HJ; Russell PS; Auchincloss H
    Transplant Proc; 1989 Feb; 21(1 Pt 1):519. PubMed ID: 2565056
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunosuppression by anti-interleukin-2 receptor antibody but not anti-L3T4 requires terminal complement components.
    Kelley VE; Strom TB
    Transplant Proc; 1987 Feb; 19(1 Pt 1):617. PubMed ID: 3274827
    [No Abstract]   [Full Text] [Related]  

  • 20. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.